1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Furui, J.
Uegaki, K.
Yamazaki, T.
Shirakawa, M.
Swindells, M.B.
Harada, H.
Taniguchi, T.
Kyogoku, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
6
491
500
10.1016/S0969-2126(98)00050-1
9562558
Solution structure of the IRF-2 DNA-binding domain: a novel subgroup of the winged helix-turn-helix family.
1998
NE
FEBS Lett.
FEBLAL
0165
0014-5793
359
184
Secondary Structure and Folding Topology of the DNA Binding Domain of Interferon Regulatory Factor 2, as Revealed by NMR Spectroscopy
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
13354.515
INTERFERON REGULATORY FACTOR-2
RESIDUES 2-113
1
man
polymer
no
no
PVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKANF
RCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLP
PVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKANF
RCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLP
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
Escherichia
sample
BL21
NUCLEUS
POTENTIAL
10090
Mus musculus
562
Escherichia coli
BL21 LAMBDA DE3
BL21
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1998-01-28
1
1
2008-03-03
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1997-11-24
REL
THE AVERAGE STRUCTURE OF 20 STRUCTURES WITH THE LOWEST TARGET FUNCTIONS
100
1
15N-EDITED 3D NOESY
13C -EDITED 3D NOESY
2D NOESY
5.70
298.00
K
ENERGY INCLUDING L-J POTENTIAL, ELECTROSTATIC POTENTIAL AND EXPERIMENTAL RESTRAINTS WAS MINIMIZED FROM AVERAGE STRUCTURE.
simulated annealing
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
3.1
500
Bruker
AMX500
600
JEOL
ARX500
600
JEOL
ALPHA600
PRO
2
n
1
PRO
2
A
VAL
3
n
2
VAL
3
A
GLU
4
n
3
GLU
4
A
ARG
5
n
4
ARG
5
A
MET
6
n
5
MET
6
A
ARG
7
n
6
ARG
7
A
MET
8
n
7
MET
8
A
ARG
9
n
8
ARG
9
A
PRO
10
n
9
PRO
10
A
TRP
11
n
10
TRP
11
A
LEU
12
n
11
LEU
12
A
GLU
13
n
12
GLU
13
A
GLU
14
n
13
GLU
14
A
GLN
15
n
14
GLN
15
A
ILE
16
n
15
ILE
16
A
ASN
17
n
16
ASN
17
A
SER
18
n
17
SER
18
A
ASN
19
n
18
ASN
19
A
THR
20
n
19
THR
20
A
ILE
21
n
20
ILE
21
A
PRO
22
n
21
PRO
22
A
GLY
23
n
22
GLY
23
A
LEU
24
n
23
LEU
24
A
LYS
25
n
24
LYS
25
A
TRP
26
n
25
TRP
26
A
LEU
27
n
26
LEU
27
A
ASN
28
n
27
ASN
28
A
LYS
29
n
28
LYS
29
A
GLU
30
n
29
GLU
30
A
LYS
31
n
30
LYS
31
A
LYS
32
n
31
LYS
32
A
ILE
33
n
32
ILE
33
A
PHE
34
n
33
PHE
34
A
GLN
35
n
34
GLN
35
A
ILE
36
n
35
ILE
36
A
PRO
37
n
36
PRO
37
A
TRP
38
n
37
TRP
38
A
MET
39
n
38
MET
39
A
HIS
40
n
39
HIS
40
A
ALA
41
n
40
ALA
41
A
ALA
42
n
41
ALA
42
A
ARG
43
n
42
ARG
43
A
HIS
44
n
43
HIS
44
A
GLY
45
n
44
GLY
45
A
TRP
46
n
45
TRP
46
A
ASP
47
n
46
ASP
47
A
VAL
48
n
47
VAL
48
A
GLU
49
n
48
GLU
49
A
LYS
50
n
49
LYS
50
A
ASP
51
n
50
ASP
51
A
ALA
52
n
51
ALA
52
A
PRO
53
n
52
PRO
53
A
LEU
54
n
53
LEU
54
A
PHE
55
n
54
PHE
55
A
ARG
56
n
55
ARG
56
A
ASN
57
n
56
ASN
57
A
TRP
58
n
57
TRP
58
A
ALA
59
n
58
ALA
59
A
ILE
60
n
59
ILE
60
A
HIS
61
n
60
HIS
61
A
THR
62
n
61
THR
62
A
GLY
63
n
62
GLY
63
A
LYS
64
n
63
LYS
64
A
HIS
65
n
64
HIS
65
A
GLN
66
n
65
GLN
66
A
PRO
67
n
66
PRO
67
A
GLY
68
n
67
GLY
68
A
ILE
69
n
68
ILE
69
A
ASP
70
n
69
ASP
70
A
LYS
71
n
70
LYS
71
A
PRO
72
n
71
PRO
72
A
ASP
73
n
72
ASP
73
A
PRO
74
n
73
PRO
74
A
LYS
75
n
74
LYS
75
A
THR
76
n
75
THR
76
A
TRP
77
n
76
TRP
77
A
LYS
78
n
77
LYS
78
A
ALA
79
n
78
ALA
79
A
ASN
80
n
79
ASN
80
A
PHE
81
n
80
PHE
81
A
ARG
82
n
81
ARG
82
A
CYS
83
n
82
CYS
83
A
ALA
84
n
83
ALA
84
A
MET
85
n
84
MET
85
A
ASN
86
n
85
ASN
86
A
SER
87
n
86
SER
87
A
LEU
88
n
87
LEU
88
A
PRO
89
n
88
PRO
89
A
ASP
90
n
89
ASP
90
A
ILE
91
n
90
ILE
91
A
GLU
92
n
91
GLU
92
A
GLU
93
n
92
GLU
93
A
VAL
94
n
93
VAL
94
A
LYS
95
n
94
LYS
95
A
ASP
96
n
95
ASP
96
A
ARG
97
n
96
ARG
97
A
SER
98
n
97
SER
98
A
ILE
99
n
98
ILE
99
A
LYS
100
n
99
LYS
100
A
LYS
101
n
100
LYS
101
A
GLY
102
n
101
GLY
102
A
ASN
103
n
102
ASN
103
A
ASN
104
n
103
ASN
104
A
ALA
105
n
104
ALA
105
A
PHE
106
n
105
PHE
106
A
ARG
107
n
106
ARG
107
A
VAL
108
n
107
VAL
108
A
TYR
109
n
108
TYR
109
A
ARG
110
n
109
ARG
110
A
MET
111
n
110
MET
111
A
LEU
112
n
111
LEU
112
A
PRO
113
n
112
PRO
113
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLU
92
A
O
GLU
91
A
N
ARG
110
A
N
ARG
109
A
O
ARG
107
A
O
ARG
106
A
N
ILE
36
A
N
ILE
35
A
O
ILE
33
A
O
ILE
32
A
N
ASN
28
A
N
ASN
27
1
A
A
OG1
HZ3
THR
LYS
62
64
1.36
1
A
A
OD1
HZ2
ASN
LYS
28
31
1.37
1
A
A
HH21
OG
ARG
SER
97
98
1.37
1
A
A
HZ1
OD1
LYS
ASN
64
80
1.37
1
A
A
O
HH21
ALA
ARG
41
43
1.38
1
A
A
OD1
HZ2
ASP
LYS
73
75
1.38
1
A
A
HZ2
OE1
LYS
GLN
25
35
1.38
1
A
A
O
HZ1
ARG
LYS
43
78
1.39
1
A
A
OD2
HZ3
ASP
LYS
96
100
1.39
1
A
A
OD1
HZ1
ASP
LYS
70
71
1.40
1
A
A
O
HH22
VAL
ARG
3
5
1.41
1
A
A
OE1
HZ3
GLU
LYS
49
50
1.42
1
A
A
OD2
HZ2
ASP
LYS
47
50
1.43
1
A
A
HZ3
O
LYS
ASP
95
96
1.44
1
A
A
O
HH11
ARG
ARG
5
7
1.46
1
A
A
HH21
OD1
ARG
ASN
82
86
1.46
1
A
A
O
HG1
TRP
THR
58
62
1.47
1
A
A
OE2
HZ1
GLU
LYS
30
31
1.47
1
A
A
O
HZ2
ILE
LYS
99
101
1.47
1
A
A
HH12
OXT
ARG
PRO
9
113
1.51
1
A
A
OE2
HG
GLU
SER
14
18
1.52
1
A
A
H2
OE1
PRO
GLU
2
4
1.52
1
A
A
OE2
HZ3
GLU
LYS
13
29
1.52
1
A
A
O
HZ1
ASP
LYS
47
50
1.53
1
A
A
O
HZ1
GLY
LYS
23
25
1.53
1
A
A
OE1
HH11
GLU
ARG
92
110
1.54
1
A
A
OD2
HG1
ASP
THR
73
76
1.55
1
A
A
O
H
ASN
HIS
57
61
1.57
1
A
A
O
H
LEU
ASP
88
90
1.59
1
A
ARG
5
0.299
SIDE CHAIN
1
A
ARG
7
0.314
SIDE CHAIN
1
A
ARG
9
0.298
SIDE CHAIN
1
A
ARG
43
0.268
SIDE CHAIN
1
A
ARG
56
0.305
SIDE CHAIN
1
A
ARG
82
0.278
SIDE CHAIN
1
A
ARG
97
0.266
SIDE CHAIN
1
A
ARG
107
0.091
SIDE CHAIN
1
A
ARG
110
0.314
SIDE CHAIN
1
A
VAL
3
-107.19
68.68
1
A
ARG
7
80.67
125.74
1
A
ASN
19
63.78
60.18
1
A
PRO
22
-68.30
78.94
1
A
TRP
38
71.70
179.07
1
A
MET
39
-101.33
46.06
1
A
HIS
44
-128.09
-80.01
1
A
TRP
46
-149.77
-89.86
1
A
ILE
69
-121.01
-50.18
1
A
SER
87
-114.97
-158.27
1
A
LEU
88
34.35
93.57
1
A
PRO
89
-66.68
44.76
1
A
ASP
90
-148.08
12.60
1
A
ASP
96
68.94
174.56
1
A
ARG
97
-137.99
-52.93
1
A
SER
98
-143.13
33.71
1
A
ILE
99
-132.46
-77.06
1
A
ASN
103
-173.09
-57.65
1
A
ASN
104
-145.71
-52.21
1
A
ALA
105
63.61
63.81
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
INTERFERON REGULATORY FACTOR-2
INTERFERON REGULATORY FACTOR-2 DNA BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
MET
8
A
MET
7
HELX_P
A
SER
18
A
SER
17
1
H1
11
A
ALA
52
A
ALA
51
HELX_P
A
HIS
61
A
HIS
60
1
H2
10
A
PRO
74
A
PRO
73
HELX_P
A
MET
85
A
MET
84
1
H3
12
TRANSCRIPTION REGULATION
TRANSCRIPTION REGULATION, WINGED HELIX-TURN-HELIX
IRF2_MOUSE
UNP
1
1
P23906
MPVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKAN
FRCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLPLSERPSKKGKKPKTEKEERVKHIKQEPVESSLGLSNGVSGFSPEYAV
LTSAIKNEVDSTVNIIVVGQSHLDSNIEDQEIVTNPPDICQVVEVTTESDDQPVSMSELYPLQISPVSSYAESETTDSVA
SDEENAEGRPHWRKRSIEGKQYLSNMGTRNTYLLPSMATFVTSNKPDLQVTIKEDSCPMPYNSSWPPFTDLPLPAPVTPT
PSSSRPDRETRASVIKKTSDITQARVKSC
2
113
1IRF
2
113
P23906
A
1
1
112
4
anti-parallel
anti-parallel
anti-parallel
A
ILE
91
A
ILE
90
A
VAL
94
A
VAL
93
A
ARG
107
A
ARG
106
A
MET
111
A
MET
110
A
ILE
33
A
ILE
32
A
ILE
36
A
ILE
35
A
LYS
25
A
LYS
24
A
ASN
28
A
ASN
27
1
P 1